Description:
West Bengal, India. 29th August 2022. AstraZeneca's famous type 2 diabetes drug Dapagliflozin known as Forxiga (EU) or Farxiga (US) led to significant reductions in the risk of hospitalization and death in people with all types of heart failure as first heart failure medication, according to study data of 'DELIVERâ released by the European Society of Cardiology congress in Barcelona. The Forxiga, belonging to a class of medicines called SGLT2 inhibitors, is displayed at a pharmacy at Tehatta.
Description:
West Bengal, India. 29th August 2022. AstraZeneca's famous type 2 diabetes drug Dapagliflozin known as Forxiga (EU) or Farxiga (US) led to significant reductions in the risk of hospitalization and death in people with all types of heart failure as first heart failure medication, according to study data of 'DELIVERâ released by the European Society of Cardiology congress in Barcelona. The Forxiga, belonging to a class of medicines called SGLT2 inhibitors, is displayed at a pharmacy at Tehatta.
Date Created:
2022-08-29 00:00:00
Author:
Soumyabrata Roy
Copyright Notice:
Soumyabrata Roy/ Majority World
Filename:
_DSC2855.jpg
File Date/Time:
1661767012
File Size:
9602856
File Type:
2
Mime Type:
image/jpeg
Sections Found:
ANY_TAG, IFD0, THUMBNAIL, EXIF
Image Description:
West Bengal, India. 29th August 2022. AstraZeneca's famous type 2 diabetes drug Dapagliflozin known as Forxiga (EU) or Farxiga (US) led to significant reductions in the risk of hospitalization and death in people with all types of heart failure as first h